Iradimed (IRMD) Assets Average (2014 - 2026)

Iradimed (IRMD) has 13 years of Assets Average data on file, last reported at $111.6 million in Q1 2026.

• Quarterly Assets Average rose 11.55% year-over-year to $111.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $111.6 million (up 11.55% YoY) and the FY2025 annual result came in at $103.6 million, up 8.73% from the prior year.
• Assets Average steadied at $111.6 million in Q1 2026 per IRMD's latest filing, from $111.7 million in the prior quarter.
• Across five years, Assets Average topped out at $111.7 million in Q4 2025 and bottomed at $74.1 million in Q2 2022.
• The 5-year median for Assets Average is $89.8 million (2023), against an average of $91.2 million.
• The widest annual swing landed in 2022, when Assets Average climbed 0.24%; it then rose 20.07% in 2025.
• Tracing IRMD's Assets Average over 5 years: stood at $82.5 million in 2022, then climbed by 8.79% to $89.8 million in 2023, then grew by 7.25% to $96.3 million in 2024, then gained by 16.06% to $111.7 million in 2025, then dropped by 0.15% to $111.6 million in 2026.
• Per Business Quant, the three latest IRMD Assets Average figures stand at $111.6 million (Q1 2026), $111.7 million (Q4 2025), and $110.6 million (Q3 2025).

Peer Comparison